- Home
- SPRY vs INVA Comparison
SPRY vs INVA Comparison
Compare SPRY & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- INVA
- Stock Information
- Founded
- SPRY 2015
- INVA 1996
- Country
- SPRY United States
- INVA United States
- Employees
- SPRY N/A
- INVA N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- SPRY Health Care
- INVA Health Care
- Exchange
- SPRY Nasdaq
- INVA Nasdaq
- Market Cap
- SPRY 1.6B
- INVA 1.4B
- IPO Year
- SPRY N/A
- INVA 2004
- Fundamental
- Price
- SPRY $16.95
- INVA $19.21
- Analyst Decision
- SPRY Strong Buy
- INVA Buy
- Analyst Count
- SPRY 4
- INVA 1
- Target Price
- SPRY $28.75
- INVA $55.00
- AVG Volume (30 Days)
- SPRY 1.5M
- INVA 1.0M
- Earning Date
- SPRY 08-05-2025
- INVA 07-30-2025
- Dividend Yield
- SPRY N/A
- INVA N/A
- EPS Growth
- SPRY N/A
- INVA N/A
- EPS
- SPRY N/A
- INVA N/A
- Revenue
- SPRY $97,122,000.00
- INVA $369,844,000.00
- Revenue This Year
- SPRY N/A
- INVA $3.75
- Revenue Next Year
- SPRY $140.40
- INVA $12.62
- P/E Ratio
- SPRY N/A
- INVA N/A
- Revenue Growth
- SPRY 971120.00
- INVA 18.70
- 52 Week Low
- SPRY $8.77
- INVA $16.19
- 52 Week High
- SPRY $18.90
- INVA $22.00
- Technical
- Relative Strength Index (RSI)
- SPRY 55.33
- INVA 33.89
- Support Level
- SPRY $15.75
- INVA $19.68
- Resistance Level
- SPRY $18.90
- INVA $21.97
- Average True Range (ATR)
- SPRY 1.04
- INVA 0.58
- MACD
- SPRY 0.01
- INVA -0.30
- Stochastic Oscillator
- SPRY 49.26
- INVA -0.94
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.